Literature DB >> 12892535

Mechanism of action of newer anticonvulsants.

H Steve White1.   

Abstract

Bipolar disorder, like epilepsy, is episodic in nature. It should not be surprising, then, that anticonvulsants such as carbamazepine and valproate have proven efficacy as mood stabilizers. The newer anticonvulsants-agents like lamotrigine, gabapentin, topiramate, oxcarbazepine, and zonisamide-may also be effective treatments for bipolar disorder. Identifying an anticonvulsant for use in bipolar disorder should take into account not only the pathophysiology of bipolar disorder but also the mechanism of action of the anticonvulsant. This article will explore the mechanisms of action of the newer anticonvulsants and their relationship to the pathophysiology of bipolar disorder in an attempt to determine which of these agents might make effective mood stabilizers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892535

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  14 in total

Review 1.  Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Placebo-controlled trial of zonisamide for the treatment of alcohol dependence.

Authors:  Albert J Arias; Richard Feinn; Cheryl Oncken; Jonathan Covault; Henry R Kranzler
Journal:  J Clin Psychopharmacol       Date:  2010-06       Impact factor: 3.153

3.  Preclinical Comparison of Mechanistically Different Antiseizure, Antinociceptive, and/or Antidepressant Drugs in a Battery of Rodent Models of Nociceptive and Neuropathic Pain.

Authors:  Misty D Smith; Jose H Woodhead; Laura J Handy; Timothy H Pruess; Fabiola Vanegas; Erin Grussendorf; Joel Grussendorf; Karen White; Karolina K Bulaj; Reisa K Krumin; Megan Hunt; Karen S Wilcox
Journal:  Neurochem Res       Date:  2017-05-15       Impact factor: 3.996

Review 4.  Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients.

Authors:  Bankole A Johnson; Nassima Ait-Daoud
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

Review 5.  Anticonvulsants for the treatment of alcohol withdrawal syndrome and alcohol use disorders.

Authors:  Christopher J Hammond; Mark J Niciu; Shannon Drew; Albert J Arias
Journal:  CNS Drugs       Date:  2015-04       Impact factor: 5.749

6.  Managing bipolar depression.

Authors:  Raymond Pary; Paul R Matuschka; Susan Lewis; Steven Lippmann
Journal:  Psychiatry (Edgmont)       Date:  2006-02

Review 7.  Topiramate and cognitive impairment: evidence and clinical implications.

Authors:  Marco Mula
Journal:  Ther Adv Drug Saf       Date:  2012-12

Review 8.  The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders.

Authors:  Christopher J Hammond
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2016-08-02

9.  Inhibition of the betaine-GABA transporter (mGAT2/BGT-1) modulates spontaneous electrographic bursting in the medial entorhinal cortex (mEC).

Authors:  Misty D Smith; Gerald W Saunders; Rasmus P Clausen; Bente Frølund; Povl Krogsgaard-Larsen; Orla M Larsson; Arne Schousboe; Karen S Wilcox; H Steve White
Journal:  Epilepsy Res       Date:  2008-02-08       Impact factor: 3.045

Review 10.  Topiramate for essential tremor.

Authors:  Elisa Bruno; Alessandra Nicoletti; Graziella Quattrocchi; Roberta Allegra; Graziella Filippini; Carlo Colosimo; Mario Zappia
Journal:  Cochrane Database Syst Rev       Date:  2017-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.